Converge Bio

Converge Bio is redefining the intersection of biology and artificial intelligence.

Foundation models and research Health and bio

Latest funding

$25M Series A · January 13, 2026

Led by Bessemer Venture Partners · Source: techcrunch.com

Total raised: $30.5M across 2 sourced rounds

All 2 rounds ↓

Website: converge-bio.com.

X: @Converge_Bio · 509 followers.

LinkedIn: converge-bio.

Categories: Foundation models and research Health and bio.

Sectors: Artificial Intelligence (AI), Biotechnology, Medical.

Stage: Series A.

Based in: Tel Aviv, Israel.

Total raised: $30.5M in 2 sourced rounds.

Last round: Jan 13, 2026 · 306 days ago.

On Recent Funding since: Sep 29, 2026.

Signals

X account@Converge_Bio · created Nov 11, 2024 (2 years old) · 509 followers

Website registeredJan 30, 2024 (2 years old)

About Converge Bio

Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs, faster leveraging the power of Generative AI and Large Language Models (LLMs) trained on biological languages.

TIMELINE · MONEY RAISED

Converge Bio | 295 days from website to first raise on record

@Converge_Bio·Raised $31M in 2 sourced rounds·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

Date	Round	Amount	Lead	Source
Jan 13, 2026	Series A	$25M	BBessemer Venture Partners	techcrunch.com
Nov 20, 2024	Seed	$5.5M	TTLV Partners	siliconangle.com

Timeline

November 11, 2024
X account created
January 30, 2024
Website created

Founders and team

DG
Dov Gertz CEO & Co-Founder

@DovGertz · source: converge-bio.com
OK
Oded Kalev CTO & Co-Founder

LinkedIn · source: converge-bio.com
IW
Iddo Weiner CSO & Co-Founder

LinkedIn · source: converge-bio.com

Investors

Companies like Converge Bio

FFireworks AI$1.5B Series B+ · Jul 2026
FFixieSeed
AAlea Health
AAnyuan Pharmaceuticals$33.02M · Oct 2026
EElement Biosciences$175M Series B+ · Jun 2026
SStackAI$16M Series A · May 2025

Other companies backed by Bessemer Venture Partners

DDreeze$33M Seed · Nov 2026
TTrajectory$45M Series A · Nov 2026
SServal$150M Series B+ · Oct 2026
UUpwind$400M Series B+ · Oct 2026
BBedrock Robotics$600M Series B+ · Oct 2026
CChapter Home$6.65M · Oct 2026

Bessemer Venture Partners portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/converge-bio (get a free API key).